Oncopeptides AB’s Rights Offering

Vinge advised Oncopeptides AB on the deal. Oncopeptides AB (publ) finalized a fully guaranteed rights issuance which will provide Oncopeptides with issue proceeds of approximately SEK...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

CTEK’s SEK 350 Million Rights Offering

Vinge advised CTEK on the deal. CTEK AB announced a fully guaranteed rights issue, which will provide CTEK with issue proceeds of approximately SEK 350 million before...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Re:NewCell’s Shares Offering

Baker McKenzie advised Nordea and Pareto on the deal. Vinge has advised Re:NewCell. Re:NewCell AB (publ) has carried out a primary issuance of shares of approximately...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Azelio’s Preferential Rights Offering

Baker McKenzie advised Carnegie and Pareto Securities on the offering. Vinge has advised Azelio. Azelio AB executed a a fully guaranteed preferential rights issuance of approximately SEK...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here